Inappropriate Ordering, Prescribing or Dispensing of Medications to Treat COVID-19


This joint statement was issued by the AMA, APhA, and ASHP to address the inappropriate use of medications to treat COVID-19. This statement reminds physicians, pharmacists, and health systems of their role as stewards of health care resources during this pandemic.


It goes on to discourage prophylactic use of medications such as chloroquine, hydroxychloroquine, and azithromycin to prevent COVID-19 and cautions that no treatment has been approved by the FDA for COVID-19. Through this statement, the organizations support direct prescribing of medications for a specific medical purpose.

Read Statement

Need More COVID-19 Resources?

Visit Toolkit

Content Related to this Article

04.25.2022
Article

Adverse Medical Events: How the RaDonda Vaught Case Could Impact Healthcare

Adverse medication events pose a significant risk to patients, healthcare staff, and the healthcare systems. However, foc...

Learn More

10.13.2021
Article

Can Employers Be Held Liable For COVID-19 Vaccine Adverse Reactions?

LHA Trust Funds Vice President of Claims Jesse Eusay discusses potential workers’ compensation risks employers may face f...

Learn More

08.26.2021
Article

Hand Hygiene: Educate Your Staff

Download the LHA Trust Funds Hand Hygiene Staff Education guide! Handwashing is a simple infection control method that ca...

Learn More